NM-2-AI
Discover related
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| PsychonautWiki | TripSit | Pharmacology | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | ≈ | ||
| Safety | ||||
| Addiction potential | moderately addictive with a high potential for abuse | — | — | |
| Toxicity | exact toxic dosage is unknown | — | — | |
| Dangerous interactions | — | — | ||
| Unsafe interactions | — | — | ||
| Dose · Oral | ||||
| Threshold | 5 mg | — | — | |
| Light | 50–100 mg | 50–100 mg | — | = |
| Common | 100–150 mg | — | — | |
| Strong | 150–200 mg | — | — | |
| Heavy | 200 mg+ | — | — | |
| Duration | ||||
| Onset | 30–60 minutes | 15–45 minutes | — | ≠ |
| Total | 2–4 hours | 3–5 hours | — | ≠ |
| After-effects | — | 1–8 hours | — | |
| Pharmacology | ||||
Dose at a glance
Each database's primary-route ladder on one shared scale — see where ranges line up or shift.
Duration at a glance
Total duration on one shared scale.
TripSit summary
Stimulant that is in the aminoindane class. Is it quite close to it's bigger brother 2-AI. Yet this has a lower potency, has a longer duration though.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.